BackInspire Medical Systems Overview
Inspire Medical Systems Inc

Inspire Medical Systems Target Price

Analysts' average 12-month price target for Inspire Medical Systems is $55.

Get informed when a big investor buys or sells

+ Follow

Share Price

$63.08

Average Target Price

$55.1312.6% downside

16 analysts in the last 4 months

High: $85 | Low: $39

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-04Evercore ISI$5414.4% downsideOpen
2026-08-04Truist Financial$621.7% downsideOpen
2026-08-04RBC CapitalShagun Singh$604.9% downsideOpen
2026-08-04Stifel Nicolaus$7518.9% upsideOpen
2026-08-04Oppenheimer$8534.7% upsideOpen
2026-08-04Piper Sandler$604.9% downsideOpen
2026-08-04Robert W. Baird$596.5% downsideOpen
2026-07-28UBSPatrick Wood$3938.2% downsideOpen
2026-07-16Truist Financial$5414.4% downsideOpen
2026-06-23Evercore ISIDaniel Markowitz$4036.6% downsideOpen
2026-05-22Summit Redstone Partners$3938.2% downsideOpen
2026-05-05Truist FinancialRichard Newitter$5020.7% downsideOpen
2026-05-05RBC Capital$4528.7% downsideOpen
2026-05-05Evercore ISI$5512.8% downsideOpen
2026-05-05Robert W. BairdDavid Rescott$5020.7% downsideOpen
2026-05-05Piper SandlerAdam Maeder$5512.8% downsideOpen
2026-04-15Truist Financial$641.5% upsideOpen
2026-04-14RBC CapitalShagun Singh$5611.2% downsideOpen
2026-04-13Mizuho Securities$7011% upsideOpen
2026-04-10Stifel Nicolaus$7011% upsideOpen
2026-03-05Stifel NicolausJonathan Block$8534.7% upsideOpen
2026-02-18Morgan Stanley$604.9% downsideOpen
2026-02-13UBS$676.2% upsideOpen
2026-02-12RBC Capital$687.8% upsideOpen
2026-02-12Stifel Nicolaus$9550.6% upsideOpen
2026-02-12Piper Sandler$8534.7% upsideOpen
2026-02-12Mizuho Securities$8534.7% upsideOpen
2026-02-12Wells Fargo$7011% upsideOpen
2026-02-12Robert W. Baird$7417.3% upsideOpen
2026-01-27RBC Capital$9042.7% upsideOpen
2026-01-22UBS$9652.2% upsideOpen
2026-01-22Truist FinancialRichard Newitter$9652.2% upsideOpen
2026-01-22Evercore ISIDaniel Markowitz$12598.2% upsideOpen
2026-01-14Wells Fargo$145129.9% upsideOpen
2026-01-08Truist FinancialRichard Newitter$12090.2% upsideOpen
2025-12-23UBSDanielle Antalffy$9144.3% upsideOpen
2025-12-17RBC Capital$175177.4% upsideOpen
2025-12-17Mizuho Securities$130106.1% upsideOpen
2025-12-08Oppenheimer$175177.4% upsideOpen
2025-12-08Piper Sandler$165161.6% upsideOpen
2025-12-04Robert W. Baird$180185.4% upsideOpen
2025-12-02Morgan Stanley$130106.1% upsideOpen
2025-11-25Truist Financial$165161.6% upsideOpen
2025-11-25Wolfe Research$180185.4% upsideOpen
2025-11-24Truist Financial$128102.9% upsideOpen
2025-11-24Stifel NicolausJonathan Block$11074.4% upsideOpen
2025-11-04RBC Capital$12598.2% upsideOpen
2025-11-04Piper SandlerGAAP EPS$135114% upsideOpen
2025-11-04Mizuho SecuritiesAnthony Petrone$11074.4% upsideOpen
2025-11-04Wells FargoLawrence Biegelsen$9042.7% upsideOpen

Inspire Medical Systems (INSP) FAQ

Inspire Medical Systems's target price stands at $55. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $55 for INSP implies 12.6% downside versus today's price ($63.08). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Inspire Medical Systems's target price evolved across reporting periods, while the comparison chart places INSP next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, target price is commonly used to spot outliers. Inspire Medical Systems's reading of $55 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.